Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Also known as Valganciclovir Hydrochloride, Valcyte
Valganciclovir · 2 trials · 1 indication
| Arm | Type | Description |
|---|---|---|
| Valganciclovir Hydrochloride Tablets 450 mg | EXPERIMENTAL | Valganciclovir Hydrochloride Tablets 450 mg of Dr. Reddys Laboratories Limited |
| Valcyte | ACTIVE_COMPARATOR | Valcyte® 450 mg tablets of Genentech USA Inc., Sanfrancisco |
| Name | Type | Description |
|---|---|---|
| Valganciclovir Hydrochloride | DRUG | Valganciclovir Hydrochloride Tablets 450 mg |
Inclusion Criteria: * Healthy, adult, human volunteers between 18 to 55 years of age (both inclusive) living in and around Ahmedabad city or western part of lndia * Having a Body Mass Index (BMD between 18.5 - 24.9 (both inclusive), calculated as weight in kg / height in meter2 * Not having any sig...
Valganciclovir is a small molecule drug developed by Dr. Reddy's Laboratories Ltd, which trades under the ticker RDY. It is being studied in Phase 1 clinical development. The specific medical conditions it is intended to treat have not been disclosed. It is also known as Valganciclovir Hydrochloride.
Valganciclovir is developed by Dr. Reddy's Laboratories Ltd, a pharmaceutical company listed under the ticker RDY. The company is conducting clinical development of the drug, which is currently in Phase 1 testing.
Valganciclovir is in Phase 1 clinical development. Two Phase 1 trials have been completed, and no trials are currently active. The drug is investigational and has not been approved by the FDA for any indication based on the available information.
Valganciclovir has been evaluated in two completed Phase 1 bioavailability trials. NCT02297854 studied 450 mg tablets under fasting conditions in 83 healthy volunteers in India. NCT02296723 studied the same tablets under fed conditions in 66 healthy volunteers in India. Both trials are completed.
Yes, Valganciclovir Hydrochloride is an alternative name for Valganciclovir. The two names refer to the same drug asset developed by Dr. Reddy's Laboratories Ltd. The clinical trials listed for this drug use the name Valganciclovir Hydrochloride.